Organ Care Products Market is expected to reach US$ 272.16 million by 2028


PRESS RELEASE BY The Insight Partners 14 Mar 2022

Share this press on


Trolley Segment to Hold Largest Share of Organ Care Products Market During 2021–2028

 

According to our new research study on "Organ Care Products Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Modality, Organ Type, and End User," the market is expected to reach US$ 272.16 million by 2028 from US$ 98.46 million in 2021; it is estimated to grow at a CAGR of 15.6% from 2021 to 2028. The report highlights trends prevailing in the market and factors governing its growth. The rising prevalence of organ failure and transplant procedures and new product launches and approvals are expected to fuel the growth of the organ care products market. However, the high cost of organ transplantation and cultural barriers are expected to restrict the market growth during the forecast period.

 

Based on modality, the organ care products market is segmented into trolley and portable. The trolley segment held a larger share of the organ care products market in 2021, and the portable segment is expected to register a higher CAGR during the forecast period. Trolley-based devices are widely utilized and available in a large number of facilities. Trolley-based storage is most common in all organ storage facilities. The ease in movement during the organ transportation with trolley systems will help the market growth. Furthermore, an increase in the number of installations at various transplantation facilities, the convenience of handling, and the associated benefit of reusability pave the way for more widespread adoption of the segment. However, organ transportation has become more convenient due to the development of compact, portable organ care products. The portable device aids in time management when storing the organ, improves organ quality, and is secure to carry and operate. TransMedics was the first to introduce the way of transporting the donated organ, and it was the only method approved by the US Food and Drug Administration (FDA). For instance, the TransMedics Organ Care System (OCS) for heart and lung are portable organ perfusion system, ventilation, and monitoring medical equipment that is used to keep standard criteria in place for transplantation. Thus, increasing trend of portable organ care products are further expected to escalate the organ care products market growth.

 

Impact of COVID-19 Pandemic on Organ Care Products Market

 

The COVID-19 pandemic has adversely affected healthcare services, and there was a significant reduction in non-urgent medical services. The governments-imposed lockdowns to prevent the spread of COVID-19, and only urgent medical care was provided, along with telehealth services. The organ donation and transplantation procedures were on halt due to the COVID-19. The immunocompromised nature of the patient was also expected to complicate the patient's condition. On the other hand, COVID-19 has affected the execution of various lifesaving procedures and stringent regulatory policies to prevent the spread of infection has severely impacted the opportunities for waiting list patients.

Furthermore, the pandemic has led to the implementation of new practices for issues regarding adequate donor evaluation and consent, organ recovery, organ procurement organization, and donor hospital resources, as well as the transplant centers' acceptance of organs offered for candidates. Additionally, to avoid the spread of COVID-19 infection from donor to recipient there are few guidelines released by some transplant societies which involves vaccination at least two weeks prior to transplantation. For instance, International Society for Heart and Lung Transplantation's (ISHLT) advice and guidance; the American Society of Transplantation (AST) also recommends vaccination at least two weeks prior to transplantation. In addition, a decrease in the number of potential deceased organ donors, saturation of healthcare systems and ICU capacities, limited access to donor and recipient testing for the infection, and challenges in travel/transport logistics for retrieval teams and donated organs were also observed. Thus, the pandemic has negatively affected the organ care products market. However, the reopening of all medical services is expected to increase organ donation and transplant procedures, thereby promoting the organ care products market growth.

 

TransMedics; XVIVO Perfusion AB; Bridge to Life; Paragonix Technologies, Inc; OrganOx Limited; Preservation Solution, Inc.; Accord Healthcare; Dr. Franz Koehler Chemie GmbH; Waters Medical Systems LLC; and Organ Recovery Systems, Inc. are among the leading companies operating in the organ care products market.

 

The report segments the global organ care products market as follows:

 

The organ care products market is segmented based on modality, organ type, and end user. Based on modality, the market is segmented into trolley and portable. Based on organ type, the market is segmented into kidney, liver, heart, lungs, and others. By end user, the organ care products market is segmented into hospitals, ambulatory surgical centers, and others.

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

Download Free PDF Brochure